[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"x-linked-retinitis-pigmentosa\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:x-linked-retinitis-pigmentosa":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100506432",false,"NCT05874310","Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa","An Open-label, Single-center, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Intraocular Administration of FT-002 in Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa.","Inclusion Criteria:\n\n1.Subjects that are willing and able to follow study procedures; 2.Males aged 8-45 years old at the time of signing the Informed Consent Form; 4.Subjects who are confirmed with variants of RPGR ;\n\nExclusion Criteria:\n\n1.Have other retinal degenerative diseases, such as retinal degeneration caused by other known Inherited retinal disease gene variants or previously received an gene therapy product.","MALE","8 Years","45 Years",{"count":19,"type":20},18,"ESTIMATED","INTERVENTIONAL",[23],"EARLY_PHASE1","A clinical trial of gene therapy for patients with X-linked retinitis pigmentosa (XLRP).",[26],"X-Linked Retinitis Pigmentosa","RECRUITING","2023-05-23",{"date":30,"type":31},"2023-05-24","ACTUAL",{"date":33,"type":31},"2023-02-01",{"date":35,"type":20},"2027-11-01",{"name":37,"class":38},"Frontera Therapeutics","INDUSTRY",2,""]